This document is an excerpt from the EUR-Lex website
It has applied since .
OTC derivatives are generally negotiated privately. The information concerning them is consequently only available to the contracting parties, which can make it difficult to identify the nature and level of risks involved.
For further information, see:
Regulation (EU) No 648/2012 of the European Parliament and of the Council of on OTC derivatives, central counterparties and trade repositories (OJ L 201, , pp. 1–59).
Successive amendments to Regulation (EU) No 648/2012 have been incorporated into the original text. This consolidated version is of documentary value only.
last update